NY Times – European Regulator Finds Little Risk in Diabetes Drugs

pills

Regulators in Europe have concluded that there is little evidence that widely used drugs to treat Type 2 diabetes could cause pancreatic inflammation or pancreatic cancer, a finding that might reassure patients while also removing a potential sales threat for Merck and some other drug companies.

Read more

Posted in Drugs